# Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies

> **NCT01682226** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 84 (actual)

## Conditions studied

- Leukemia
- Myelodysplastic Syndrome
- Lymphoma

## Interventions

- **DEVICE:** CliniMACS Fractionation system (Arm A)
- **DEVICE:** CliniMACS Fractionation system (Arm B)
- **BIOLOGICAL:** Haploidentical donor CD34+ cells

## Key facts

- **NCT ID:** NCT01682226
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09-05
- **Primary completion:** 2021-01-08
- **Final completion:** 2021-01-08
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2022-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01682226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01682226, "Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01682226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*